retatrutide osteoarthritis shows significant weight loss in obesity and knee trial | Ahmad Bahareth, MD posted on the topic Retatrutide for weight loss: Study

Phase 2 Trials The findings of phase 1 studies supported the continued clinical development of retatrutide as a promising candidate for the treatment of obesity and T2D

Mechanism with specific data: In fibroblast cell culture studies, GHK-Cu at concentrations of roughly 1 to 10 nanomolar activates pathways including TGF-beta1 signaling, increases mRNA expression of collagen I and III, and upregulates tissue inhibitors of metalloproteinases (TIMPs) that protect existing collagen from degradation

This separation of pathways is what makes the theoretical combination interesting from a research perspective

Lantas, apa saja manfaat dan efek samping obat glutacid sebagai pemutih kulit